XBiotech XBIT
NASDAQ XBIT
$1.91 +0.04 (+2.14%)
At close: Nov 9, 2026 · 4:00 PM EST

XBiotech (XBIT) EBT Margin (2020 - 2022)

Updated

XBiotech's EBT Margin came in at -837.61% for FY2022, down 699.20 percentage points from -138.40% in FY2021.

Analysis

XBiotech (XBIT) EBT Margin (2020 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put EBT Margin at -138.40% in FY2021 (-109.25 pp) and -29.15% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 0.13%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 27.75%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 30.74%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 26.27%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 45.21%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 36.90%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 20.41%
10 XBiotech 58.23 Mn -439.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -610.54%
Jun 30, 2022 -931.50%
Mar 31, 2022 -1,290.80%
Dec 31, 2021 -170.40%
Sep 30, 2021 -111.86%
Jun 30, 2021 -214.17%
Mar 31, 2021 -62.78%
Dec 31, 2020 -39.70%
Sep 30, 2020 -30.28%
Jun 30, 2020 -46.30%
Mar 31, 2020 -2.89%
API Access

XBiotech EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=XBIT&period=max&api_key=YOUR_API_KEY